Kimberly-Clark to buy Kenvue in $48.7 billion deal
Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies…
Editor’s Pick
21 posts